T-Cell Leukemia/lymphoma 1A (TCL1A) (N-Term) Peptide
TCL1A
Reactivity: Human
Host: Synthetic
BP, WB
-
- Target See all TCL1A products
- TCL1A (T-Cell Leukemia/lymphoma 1A (TCL1A))
- Protein Region
- N-Term
- Origin
- Human
-
Source
- Synthetic
- Application
- Blocking Peptide (BP), Western Blotting (WB)
- Characteristics
- This is a synthetic peptide designed for use in combination with anti-TCL1A antibody (Catalog #: ARP58808_P050). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
- Purification
- Purified
-
-
- Application Notes
- Each Investigator should determine their own optimal working dilution for specific applications.
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Reconstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
- Concentration
- 1 mg/mL
- Buffer
- Final peptide concentration is 1 mg/mL in PBS.
- Handling Advice
- Avoid repeated freeze-thaw cycles.
- Storage
- -20 °C
- Storage Comment
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
- Target
- TCL1A (T-Cell Leukemia/lymphoma 1A (TCL1A))
- Synonyms
- TCL1A Peptide, Tcl1a Peptide, TCL1 Peptide, Tcl1 Peptide, T-cell leukemia/lymphoma 1A Peptide, T cell lymphoma breakpoint 1 Peptide, TCL1A Peptide, Tcl1 Peptide, Tcl1a Peptide
- Background
-
TCL1A can enhance the phosphorylation and activation of AKT1, AKT2 and AKT3,promote nuclear translocation of AKT1,enhance cell proliferation, stabilize mitochondrial membrane potential and promote cell survival.
Alias Symbols: TCL1
Protein Interaction Partner: AKT1,AKT2,AKT3,AKT1,AKT2,AKT3,CALCOCO2,HIST3H2A,AKT1,AKT2,AKT3,CALCOCO2,HIST3H2A,TCL1A
Protein Size: 114 - Molecular Weight
- 13 kDa
- Gene ID
- 8115
- NCBI Accession
- NM_021966, NP_068801
- UniProt
- P56279
-
You are here:
